Research from Texas Tech University Has Provided New Study Findings on Glioblastomas (Abstract 170: Glioblastoma patient-derived organoids as a model for discovering novel markers of therapy resistance in the context of tumor microenvironment:...).

For more information on this research see: Abstract 170: Glioblastoma patient-derived organoids as a model for discovering novel markers of therapy resistance in the context of tumor microenvironment: potential role of melanoma antigens. Keywords: Antigens; Biological Factors; Biomarkers; Cancer; Diagnostics and Screening; Drugs and Therapies; Genetics; Glioblastomas; Health and Medicine; Immunofluorescence; Immunology; Immunotherapy; Melanoma; Oncology; Pharmaceuticals; Stem Cell Research; Therapy EN Antigens Biological Factors Biomarkers Cancer Diagnostics and Screening Drugs and Therapies Genetics Glioblastomas Health and Medicine Immunofluorescence Immunology Immunotherapy Melanoma Oncology Pharmaceuticals Stem Cell Research Therapy 783 783 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on glioblastomas are presented in a new report. [Extracted from the article]

Copyright of Immunotherapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)